Form 8-K - Current report:
SEC Accession No. 0001193125-25-065634
Filing Date
2025-03-27
Accepted
2025-03-27 17:20:22
Documents
59
Period of Report
2025-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831325d8k.htm   iXBRL 8-K 26840
2 EX-99.1 d831325dex991.htm EX-99.1 25069
3 EX-99.2 d831325dex992.htm EX-99.2 52110
7 GRAPHIC g831325ex99_2s10g1.jpg GRAPHIC 102882
8 GRAPHIC g831325ex99_2s11g1.jpg GRAPHIC 69294
9 GRAPHIC g831325ex99_2s12g1.jpg GRAPHIC 85488
10 GRAPHIC g831325ex99_2s13g1.jpg GRAPHIC 88329
11 GRAPHIC g831325ex99_2s14g1.jpg GRAPHIC 95094
12 GRAPHIC g831325ex99_2s15g1.jpg GRAPHIC 100307
13 GRAPHIC g831325ex99_2s16g1.jpg GRAPHIC 88309
14 GRAPHIC g831325ex99_2s17g1.jpg GRAPHIC 115771
15 GRAPHIC g831325ex99_2s18g1.jpg GRAPHIC 102082
16 GRAPHIC g831325ex99_2s19g1.jpg GRAPHIC 97198
17 GRAPHIC g831325ex99_2s1g1.jpg GRAPHIC 97390
18 GRAPHIC g831325ex99_2s20g1.jpg GRAPHIC 95615
19 GRAPHIC g831325ex99_2s21g1.jpg GRAPHIC 95001
20 GRAPHIC g831325ex99_2s22g1.jpg GRAPHIC 94348
21 GRAPHIC g831325ex99_2s23g1.jpg GRAPHIC 88094
22 GRAPHIC g831325ex99_2s24g1.jpg GRAPHIC 96198
23 GRAPHIC g831325ex99_2s25g1.jpg GRAPHIC 91107
24 GRAPHIC g831325ex99_2s26g1.jpg GRAPHIC 121991
25 GRAPHIC g831325ex99_2s27g1.jpg GRAPHIC 115254
26 GRAPHIC g831325ex99_2s28g1.jpg GRAPHIC 94003
27 GRAPHIC g831325ex99_2s29g1.jpg GRAPHIC 101440
28 GRAPHIC g831325ex99_2s2g1.jpg GRAPHIC 226855
29 GRAPHIC g831325ex99_2s30g1.jpg GRAPHIC 86041
30 GRAPHIC g831325ex99_2s31g1.jpg GRAPHIC 92372
31 GRAPHIC g831325ex99_2s32g1.jpg GRAPHIC 106735
32 GRAPHIC g831325ex99_2s33g1.jpg GRAPHIC 102158
33 GRAPHIC g831325ex99_2s34g1.jpg GRAPHIC 87507
34 GRAPHIC g831325ex99_2s35g1.jpg GRAPHIC 75866
35 GRAPHIC g831325ex99_2s36g1.jpg GRAPHIC 67256
36 GRAPHIC g831325ex99_2s37g1.jpg GRAPHIC 124213
37 GRAPHIC g831325ex99_2s38g1.jpg GRAPHIC 29333
38 GRAPHIC g831325ex99_2s39g1.jpg GRAPHIC 86600
39 GRAPHIC g831325ex99_2s3g1.jpg GRAPHIC 91356
40 GRAPHIC g831325ex99_2s40g1.jpg GRAPHIC 94743
41 GRAPHIC g831325ex99_2s41g1.jpg GRAPHIC 93509
42 GRAPHIC g831325ex99_2s42g1.jpg GRAPHIC 85196
43 GRAPHIC g831325ex99_2s43g1.jpg GRAPHIC 56250
44 GRAPHIC g831325ex99_2s44g1.jpg GRAPHIC 73141
45 GRAPHIC g831325ex99_2s4g1.jpg GRAPHIC 124456
46 GRAPHIC g831325ex99_2s5g1.jpg GRAPHIC 67180
47 GRAPHIC g831325ex99_2s6g1.jpg GRAPHIC 93928
48 GRAPHIC g831325ex99_2s7g1.jpg GRAPHIC 116610
49 GRAPHIC g831325ex99_2s8g1.jpg GRAPHIC 99092
50 GRAPHIC g831325ex99_2s9g1.jpg GRAPHIC 105726
  Complete submission text file 0001193125-25-065634.txt   6075028

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA snse-20250327.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20250327_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20250327_pre.xml EX-101.PRE 11703
61 EXTRACTED XBRL INSTANCE DOCUMENT d831325d8k_htm.xml XML 3745
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 25780585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)